title: [Muscular complications in HIV infection].
abstract: Skeletal muscle involvement may occur at all stages of HIV-infection and represents the first manifestation of the disease into some patients. We usually classify muscle involvement in HIV-infected patients in one of the following categories: HIV-associated myopathy, a myopathy that meets the criteria for polymyositis in a majority of patients, and those for acquired nemaline myopathy in some cases (1); zidovudine myopathy, a reversible mitochondrial myopathy (2); HIV-wasting syndrome and other AIDS-associated cachexias (3); opportunistic infections and tumor infiltrations of the skeletal muscle (4); vasculitic processes and iron pigment deposits (5); HIV-associated myasthenia gravis (6) and rhabdomyolysis (7). Immunohistology for major histocompatibility complex class I antigen and histochemical reaction for cytochrome coxidase are helpful in the correct classification of a myopathy as HIV polymyositis or zidovudine myopathy.
authors.affiliation: Département de Pathologie, Hôpital Henri-Mondor, Créteil, France.
authors.forename: F J
authors.initials: FJ
authors.lastname: Authier
authors.forename: P
authors.initials: P
authors.lastname: Chariot
authors.forename: R
authors.initials: R
authors.lastname: Gherardi
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D009135:Muscular Diseases / Q000139:chemically induced / Q000145:classification / Q000209:etiology* / Q000821:virology; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D015215:Zidovudine